Musculoskeletal (MSK) disease or impairments comprise more than 150 different diseases or conditions which internally affect the human system and are characterized by deficiencies in the muscles, bones, joints, and adjacent connective tissues, which lead to lifelong hindrances in functioning and participation. The conditions are characterized by pain, limited gait movement, and dexterity, thereby reducing people’s aptitude to work and participate in society.
Access full Report @ https://www.databridgemarketresearch.com/reports/north-america-musculoskeletal-msk-disease-management-market
The management of MSK diseases involves consultation with a physician, integrated with telemedicine, which uses digital biofeedback systems (DBSs), musculoskeletal-focused digital apps (MDAs), and therapies. Physical activity and weight management programs are also important self-management activities for persons with arthritis. Virtual therapy or remote consultation entails a holistic approach with the implementation of video conference and phone consultations in MSK practice.
In the coming future, important decisions related to MSK disease management on physical movement and post-surgery applications will be made by individuals who not only understand telemedicine and virtual technology but, can also use MSK disease management tools and the knowledge they release to develop hypotheses and identify quality targets.
Data Bridge Market Research analyzes that the North America Musculoskeletal (MSK) Disease Management Market is expected to grow with a CAGR of 23.0% from 2023 to 2030 and is expected to reach USD 21,318.48 million by 2030.
Key Findings of the Study
Growth in Technological Advancements
Musculoskeletal disorders (MSDs) are injuries and disorders that affect the movement of the human body in the musculoskeletal (MSK) system, such as muscles, ligaments, nerves, tendons, cartilage, and discs. Some of the more common MSK conditions are myasthenia gravis, osteoarthritis (OA), gout, rheumatoid arthritis (RA), back pain, osteoporosis, and systemic lupus erythematosus (SLE). MSK pain has various causes. For example, muscle tissue can be damaged by wear and tear during daily activities. The strain on human body parts due to sprains, car accidents, falls, jerky movements, fractures, dislocations, and direct muscle blows also cause MSK pain.
Increasing technological advancements with advanced features have resulted in the proper management of the disease for both patients and doctors, which is anticipated to boost the market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2015 – 2020)
|
|
Quantitative Units
|
Revenue in Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Type (Digital Biofeedback System, Musculoskeletal-Focused Digital Apps (MDAs), Solutions, and Others), Technology (Precision Motion Technology, Computer Vision Technology, and Other Technologies), Integration Type (Phone, Tablet, Computer, and Others), Modality (Virtual Therapy, In-Person Therapy, Customized/Personalized Therapy, and Others), Application (Pre-Surgery Application and Post-Surgery Application), Patient Population (Pediatrics, Adults, and Geriatrics), End User (Hospitals & Clinics, Nursing Homes, Health Centers, Rehabilitation Centres, Virtual/Home Health Care Settings, and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico
|
|
Market Players Covered
|
RecoveryOne (U.S), Kiio (U.S), Omada Health Inc. (U.S), DarioHealth Corp. (U.S), IncludeHealth (U.S), kaia health (U.S), IMC. (U.S), Wellness Coaches USA LLC (U.S), Sparta Science(U.S), Movement RX(U.S), Phzio (Canada), Airrosti Rehab Center LLC (U.S), SimpleTherapy Inc. (U.S), Hinge Health, Inc. (U.S), Sword Health Inc. (U.S), SPRITE HEALTH (U.S), and Limber Health Inc. (U.S) among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, competitive analysis, Brand analysis, technological trends,, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The North America musculoskeletal (MSK) disease management market is segmented into seven segments which are type, technology, integration type, modality, application, patient population, and end user.
- On the basis of type, the North America musculoskeletal (MSK) disease management market is segmented into digital biofeedback system, musculoskeletal-focused digital apps (MDAs), solutions, and others.
In 2023, the digital biofeedback system segment is anticipated to dominate the North America musculoskeletal (MSK) disease management market
In 2023, the digital biofeedback system segment is expected to dominate the North America musculoskeletal (MSK) disease management market with 51.85% market share owing to the increasing prevalence of chronic diseases and the rising adoption of monitoring devices by physicians and patients for continuous monitoring.
- On the basis of technology, the North America musculoskeletal (MSK) disease management market is segmented into precision motion technology, computer vision technology, and other technologies. In 2023, the precision motion technology segment holds the maximum market share of 58.63%.
- On the basis of integration type, the North America musculoskeletal (MSK) disease management market is segmented into phone, tablet, computer, and others. In 2023, the phone segment holds the maximum market share of 51.62%.
- On the basis of modality, the North America musculoskeletal (MSK) disease management market is segmented into virtual therapy, in-person therapy, customized/personalized therapy, and others. In 2023, the virtual therapy segment holds the maximum market share of 55.00%.
- On the basis of application, the North America musculoskeletal (MSK) disease management market is segmented into pre-surgery applications and post-surgery applications. In 2023, the pre-surgery application segment holds the maximum market share of 52.67%.
- On the basis of patient population, the North America musculoskeletal (MSK) disease management market is segmented into pediatrics, adults, and geriatrics. In 2023, the pediatrics segment holds the maximum market share of 53.66%.
- On the basis of end user, the North America musculoskeletal (MSK) disease management market is segmented into hospitals & clinics, nursing homes, health centers, rehabilitation centers, virtual/home health care settings, and others.
In 2023, the hospitals & clinics segment is projected to hold the largest share of end user segment in the North America musculoskeletal (MSK) disease management market
In 2023, the hospitals & clinics segment holds the maximum market share of 41.91% due to the rising adoption of precise and effective monitoring of patients with chronic illnesses.
Major Players
RecoveryOne (U.S), Kiio (U.S), Omada Health Inc. (U.S), DarioHealth Corp. (U.S), IncludeHealth (U.S), kaia health (U.S), IMC. (U.S), Wellness Coaches USA LLC (U.S), Sparta Science(U.S), Movement RX(U.S), Phzio (Canada), Airrosti Rehab Center LLC (U.S), SimpleTherapy Inc. (U.S), Hinge Health, Inc. (U.S), Sword Health Inc. (U.S), SPRITE HEALTH (U.S), and Limber Health Inc. (U.S) among others.
Market Developments
- In April 2022, Airrosti Rehab Center, LLC formed a partnership with Buoy Health’s innovative healthcare marketplace. The partnership resulted to bring good value MSK care to Buoy’s more than 2 million users per month and the development of novel MSK virtual products.
- In September 2021, IncludeHealth launched IncludeHealth’s MSK-OSTM. The launch resulted in approval for sale in the market and expansion of the product portfolio.
- In September 2021, Hinge Health, Inc. acquired wrnch, the developer of the leading computer vision platform for measuring human MSK motion. The acquisition resulted in Hinge Health, Inc. leveraging and distributing the virtual therapy instruments. It would result in a rise in revenue and linear market growth.
- In March 2021, Hinge Health, Inc acquired Enso. The acquisition resulted in the addition of a new product in the product range and the expansion of the product line.
- In April 2022, Airrosti Rehab Center, LLC formed a partnership with Buoy Health’s innovative healthcare marketplace. The partnership resulted to bring good value MSK care to Buoy’s more than 2 million users per month and the development of novel MSK virtual products
- In July 2021, Wellness Coaches, a leading provider of occupational health, safety, and wellness solutions, expanded its expertise in digital health with the strategic acquisition of Benovate, the next-generation digital workplace safety platform. As part of the acquisition, Wellness Coaches recently launched an enhanced Healthy Ways platform, which now uses Benovate's proprietary technology to deliver real-time, personalized wellness experiences to employees. The program seamlessly combines cutting-edge technology, predictive analytics, machine learning, and data to deliver a unique and user-friendly experience for every employee. The app's smart technology, combined with personal guidance from health coaches trained by professional trainers and registered dietitians, helps users identify and reduce health risks before they become costly health conditions.
Country Analysis
Geographically, the countries covered in the North America musculoskeletal (MSK) disease management market report are U.S., Canada, and Mexico.
As per Data Bridge Market Research analysis:
U.S is the dominant country in the North America musculoskeletal (MSK) disease management market during the forecast period 2023 -2030
In 2023, the U.S country is expected to dominate North America musculoskeletal (MSK) disease management market with a market share of 91.29%. This is due to the rising adoption of technical advancements all across the country. The rising supply of disease managment devices and the rising practice of monitoring patients are expected to drive market growth in the region.
U.S is estimated to be the fastest-growing country in the North America musculoskeletal (MSK) disease management market for the forecast period 2023-2030
U.S is expected to grow during the forecast period due to an increase in the number of healthcare facilities with advanced technology and rising launches and approvals of several RPM devices.
For more detailed information about the North America musculoskeletal (MSK) disease management market, click here – https://www.databridgemarketresearch.com/reports/north-america-musculoskeletal-msk-disease-management-market
